Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Patented compound?

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Dec 11, 2023 10:38pm

146 Views

Post# 35779209

RE:Patented compound?

JL202101 wrote: The wording of "our patented compound" is on the website below. Has the patent been granted? https://www.sironabiochem.com/programs/glycoprotemim/

If it's the "Glycopeptides Increasing Lipid Synthesis" patent application, it was published on Aug. 25, 2022 and has been sitting in limbo in the U.S. Patent Office ever since. I have no idea why there has been no action on it -- not even a rejection by an examiner!

You would think the Company would be pursuing the Patent Office -- but, maybe they have?